377 related articles for article (PubMed ID: 17641018)
21. Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.
Doody AD; Kovalchin JT; Mihalyo MA; Hagymasi AT; Drake CG; Adler AJ
J Immunol; 2004 May; 172(10):6087-92. PubMed ID: 15128793
[TBL] [Abstract][Full Text] [Related]
22. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.
Loschko J; Heink S; Hackl D; Dudziak D; Reindl W; Korn T; Krug AB
J Immunol; 2011 Dec; 187(12):6346-56. PubMed ID: 22079988
[TBL] [Abstract][Full Text] [Related]
23. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
24. DCs in immune tolerance in steady-state conditions.
Fukaya T; Takagi H; Taya H; Sato K
Methods Mol Biol; 2011; 677():113-26. PubMed ID: 20941606
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response.
Steele LN; Balsara ZR; Starnbach MN
J Immunol; 2004 Nov; 173(10):6327-37. PubMed ID: 15528372
[TBL] [Abstract][Full Text] [Related]
26. Differential requirements for Th1 and Th17 responses to a systemic self-antigen.
Katzman SD; Gallo E; Hoyer KK; Abbas AK
J Immunol; 2011 Apr; 186(8):4668-73. PubMed ID: 21402892
[TBL] [Abstract][Full Text] [Related]
27. Peripheral tolerance to a nuclear autoantigen: dendritic cells expressing a nuclear autoantigen lead to persistent anergic state of CD4+ autoreactive T cells after proliferation.
Kawahata K; Misaki Y; Yamauchi M; Tsunekawa S; Setoguchi K; Miyazaki J; Yamamoto K
J Immunol; 2002 Feb; 168(3):1103-12. PubMed ID: 11801644
[TBL] [Abstract][Full Text] [Related]
28. Limited ability of antigen-specific Th1 responses to inhibit Th2 cell development in vivo.
Yasumi T; Katamura K; Okafuji I; Yoshioka T; Meguro TA; Nishikomori R; Kusunoki T; Heike T; Nakahata T
J Immunol; 2005 Feb; 174(3):1325-31. PubMed ID: 15661889
[TBL] [Abstract][Full Text] [Related]
29. Modulation of dendritic cell function by naive and regulatory CD4+ T cells.
Veldhoen M; Moncrieffe H; Hocking RJ; Atkins CJ; Stockinger B
J Immunol; 2006 May; 176(10):6202-10. PubMed ID: 16670330
[TBL] [Abstract][Full Text] [Related]
30. TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism.
Jones SC; Brahmakshatriya V; Huston G; Dibble J; Swain SL
J Immunol; 2010 Dec; 185(11):6783-94. PubMed ID: 20980632
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
32. Induction of tolerance in CD8+ T cells to a transgenic autoantigen expressed in the liver does not require cross-presentation.
Morimoto J; Tan X; Teague RM; Ohlén C; Greenberg PD
J Immunol; 2007 Jun; 178(11):6849-60. PubMed ID: 17513733
[TBL] [Abstract][Full Text] [Related]
33. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid-induced leucine zipper enhanced expression in dendritic cells is sufficient to drive regulatory T cells expansion in vivo.
Calmette J; Ellouze M; Tran T; Karaki S; Ronin E; Capel F; Pallardy M; Bachelerie F; Krzysiek R; Emilie D; Schlecht-Louf G; Godot V
J Immunol; 2014 Dec; 193(12):5863-72. PubMed ID: 25362183
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance?
Ciavarra RP; Stephens A; Nagy S; Sekellick M; Steel C
J Immunol; 2006 Jul; 177(1):492-500. PubMed ID: 16785546
[TBL] [Abstract][Full Text] [Related]
36. Differential requirement for the CD40-CD154 costimulatory pathway during Th cell priming by CD8 alpha+ and CD8 alpha- murine dendritic cell subsets.
Yasumi T; Katamura K; Yoshioka T; Meguro TA; Nishikomori R; Heike T; Inobe M; Kon S; Uede T; Nakahata T
J Immunol; 2004 Apr; 172(8):4826-33. PubMed ID: 15067060
[TBL] [Abstract][Full Text] [Related]
37. TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses.
Chandran SS; Verhoeven D; Teijaro JR; Fenton MJ; Farber DL
J Immunol; 2009 Dec; 183(12):7832-41. PubMed ID: 19933854
[TBL] [Abstract][Full Text] [Related]
38. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo.
Oldenhove G; de Heusch M; Urbain-Vansanten G; Urbain J; Maliszewski C; Leo O; Moser M
J Exp Med; 2003 Jul; 198(2):259-66. PubMed ID: 12874259
[TBL] [Abstract][Full Text] [Related]
40. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
